You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Eyes on New Product Development—Number 133

Journal of Ocular Pharmacology and Therapeutics

Impact Factor: 2.1 / 5-Year Impact Factor: 2.3

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online 2026

Eyes on New Product Development—Number 133

https://doi.org/10.1177/10807683261456147

Abstract

Get full access to this article

View all access options for this article.

References

1.

1. Mattingly

AN

. Expanding the role of prescription drug monitoring programs. JAMA Health Forum 2026;7(4):e260273.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Cataract Surgery Under Infliximab Therapy in a Patient With Behçet’s Disease

Retricted access

Pharmacological evaluation of methanolic leaf extract of Swietenia mahagoni on acrylamide-induced neuropathic pain in rats

Retricted access

Effect of Aminoguanidine on the Conjunctival Histamine and Nitrite Levels in Experimental Conjunctivitis

Retricted access

Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate